Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Per Fauchald"'
Autor:
Ingrid Os, Per Fauchald, Per Pfeffer, Cecilia Montgomery Oien, Anna Varberg Reisæter, Torbjørn Leivestad
Publikováno v:
Nephrology Dialysis Transplantation. 20:783-789
Background. In living donor (LD) kidney transplantation, a predominance of female-to-male donations has been observed. Gender demographics of living donors and outcomes of LD kidney transplantations in Norway were assessed, as this has not been explo
Autor:
Klemens Budde, Lutz Fritsche, J. Dantal, Ingeborg A. Hauser, Jean-Paul Soulillou, Gustav Lehne, Hans-Hellmut Neumayer, Michael Winkler, Arno Lison, Per Fauchald
Publikováno v:
Nephrology Dialysis Transplantation. 19:2606-2614
Background. Current immunosuppressant regimens need to be improved to prevent acute and chronic graft rejection. The novel macrocyclic immunosuppressant everolimus (Certican TM , RAD) is currently in clinical development to address this issue. Method
Autor:
Lars Mørkrid, Karsten Midtvedt, Svend Aakhus, Thore Egeland, Per Fauchald, Anders Hartmann, Jean Stenstrøm, Jøran Hjelmesæth, Hrafnkell Tordarson
Publikováno v:
Nephrology Dialysis Transplantation. 16:1047-1052
Background. Cardiovascular disease (CVD) is the major cause of death in renal transplant recipients. Traditional risk factors like hypertension, dyslipidaemia and diabetes mellitus are common, but cannot completely account for the high prevalence of
Publikováno v:
Nephrology Dialysis Transplantation. 18:871-873
Keywords: livingkidneydonation;morbidity;mortalityLiving kidney donation has become an established partof the transplant programmes in most centres world-wide. It has indeed been an important part of our trans-plant programme for )30 years, comprisin